FDA Clearance of Aptima BV and Aptima CV/TV Molecular Assays Ushers in New Era of Comprehensive and Objective Diagnostic Testing for Vaginitis - Olean Times Herald

FDA Clearance of Aptima BV and Aptima CV/TV Molecular Assays Ushers in New Era of Comprehensive and Objective Diagnostic Testing for Vaginitis  Olean Times Herald

MARLBOROUGH, Mass.--(BUSINESS WIRE)--May 29, 2019--. Hologic, Inc. (Nasdaq: HOLX) announced today that the FDA has granted clearance for its new ...